Skip to main content

Table 2 Clinical characteristics and treatment modalities of hereditary angioedema in the studied patients

From: Clinical and laboratory spectrum of hereditary angioedema in a group of Egyptian children: a cross sectional study

Variables

n. (18)

%

Site of oedema

Face

14

77.8

Laryngeal

8

44.4

Eyes

4

22.2

Lips

4

22.2

Feet

4

22.2

Hand

4

22.2

The attacks associated with abdominal symptoms

yes

14

77.8

no

4

22.2

Trigger of the attack

Trauma

15

83.3

Spontaneous

14

77.8

Menstruation

4

22.2

stress

1

5.6

Severity Score

Mild

3

16.7

Moderate

4

22.2

Severe

11

61.1

Variable

Mean ± SD

median(range)

Number of attacks per year

23.7 ± 15.3

17(4–48)

Duration of angioedema attack (days)

2.9 ± 1.5

2 (2–7)

Variables (treatment modalities)

n. (18)

%

Treatment during the attack

Antihistamine

17

94.4

steroid

15

83.3

adrenaline

1

5.6

Plasma

1

5.6

Short-term prophylaxis

fresh frozen plasma

4

22.2

Long-term prophylaxis

Danazol

7

38.9

Danazol/(human C1 esterase inhibitor)

1

5.6